Trials show immune drugs effective in advanced melanomas

Results of two clinical trials show continued promise of immune therapies nivolumab and pembrolizumab against advanced melanomas, specifically in the context of PD1 signaling that some tumors use to avoid immune system attack. (Mehr in: Cancer News — ScienceDaily)